Abstract: The invention provides a boron suboxide composite material comprising boron suboxide and a secondary phase, wherein the secondary phase contains a boride. The boride may be selected from the borides of transition metals of the fourth to eighth groups of the periodic table. Particularly, the boride may be selected from the borides of iron, cobalt, nickel, titanium, tungsten, hafnium, tantalum, zirconium, rhenium, molybdenum or chromium. The boride also may be a platinum group metal boride, preferably palladium boride. The secondary phase also may contain one or more oxides.

Abstract: A milk or other dairy product, capable of minimising the onset of disease such as coronary heart disease or enhancing the immune response is derived from animals which are substantially free of the ?-casein A allele. Bulk milk can be produced by testing for and culling cows who test positive for the ?-casein A allele, or by producing immunoglobulins and other immune response proteins, in cow's milk from animals not possessing the ?-casein A1 allele, or other commercial milk producing animals, to this allele, to counteract the immunosuppressant substances present that are produced from it, in commercial milking cows such as Holsteins, together with its blending with non-treated milk or the recovery of such immunoproteins.

Abstract: The invention provides a boron suboxide composite material comprising boron suboxide and a secondary phase, wherein the secondary phase contains a boride. The boride may be selected from the borides of transition metals of the fourth to eighth groups of the periodic table. Particularly, the boride may be selected from the borides of iron, cobalt, nickel, titanium, tungsten, hafnium, tantalum, zirconium, rhenium, molybdenum or chromium. The boride also may be a platinum group metal boride, preferably palladium boride. The secondary phase also may contain one or more oxides.

Abstract: A milk or other dairy product, capable of minimising the onset of disease such as coronary heart disease or enhancing the immune response is derived from animals which are substantially free of the ?-casein A allele. Bulk milk can be produced by testing for and culling cows who test positive for the ?-casein A allele, or by producing immunoglobulins and other immune response proteins, in cow's milk from animals not possessing the ?-casein A1 allele, or other commercial milk producing animals, to this allele, to counteract the immunosuppressant substances present that are produced from it, in commercial milking cows such as Holsteins, together with its blending with non-treated milk or the recovery of such immunoproteins.

Abstract: A milk or other dairy product, capable of minimising the onset of disease such as coronary heart disease or enhancing the immune response is derived from animals which are substantially free of the ?-casein A1 allele. Bulk milk can be produced by testing for and culling cows who test positive for the ?-casein A1 allele, or by producing immunoglobulins and other immune response proteins, in cow's milk from animals not possessing the ?-casein A1 allele, or other commercial, milk producing animals, to this allele, to counteract the immunosuppressant substances present that are produced from it, in commercial milking cows such as Holsteins, together with its blending with non-treated milk or the recovery of such immunoproteins.

Abstract: A milk or other dairy product, capable of minimising the onset of disease such as coronary heart disease or enhancing the immune response is derived from animals which are substantially free of the ?-casein A1 allele. Bulk milk can be produced by testing for and culling cows who test positive for the ?-casein A1 allele, or by producing immunoglobulins and other immune response proteins, in cow's milk from animals not possessing the ?-casein A1 allele, or other commercial, milk producing animals, to this allele, to counteract the immunosuppressant substances present that are produced from it, in commercial milking cows such as Holsteins, together with its blending with non-treated milk or the recovery of such immunoproteins.

Abstract: A milk or other dairy product, capable of minimizing the onset of disease such as coronary heart disease or enhancing the immune response is derived from animals which are substantially free of the ?-casein A1 allele. Bulk milk can be produced by testing for and culling cows who test positive for the ?-casein A1 allele, or by producing immunoglobulins and other immune response proteins, in cow's milk from animals not possessing the ?-casein A1 allele, or other commercial milk producing animals, to this allele, to counteract the immnunosuppressant substances present that are produced from it, in commercial milking cows such as Holsteins, together with its blending with non-treated milk or the recovery of such immunoproteins.

Abstract: A milk which is free of &bgr;-casein A1 protein in the prevention or treatment of coronary heart disease is disclosed. In addition, a process for the testing of DNA from cells obtained from lactating bovines for the presence of DNA encoding certain &bgr;-casein proteins, selecting the bovines on the basis of the testing, and then milking those bovines to produce milk free of &bgr;-casein A1 for use in the prevention or treatment of coronary heart disease is disclosed.

Abstract: A milk or other dairy product, capable of minimising the onset of disease such as coronary heart disease or enhancing the immune response is derived from animals which are substantially free of the &bgr;-casein A1 allele. Bulk milk can be produced by testing for and culling cows who test positive for the &bgr;-casein A1 allele, or by producing immunoglobulins and other immune response proteins, in cow's milk from animals not possessing the &bgr;-casein A1 allele, or other commercial milk producing animals, to this allele, to counteract the immnunosuppressant substances present that are produced from it, in commercial milking cows such as Holsteins, together with its blending with non-treated milk or the recovery of such immunoproteins.

Abstract: A milk which is free of &bgr;-casein A1 protein in the prevention or treatment of coronary heart disease is disclosed. In addition, a process for the testing of DNA from cells obtained from lactating bovines for the presence of DNA encoding certain &bgr;-casein proteins, selecting the bovines on the basis of the testing, and then milking those bovines to produce milk free of &bgr;-casein A1 for use in the prevention or treatment of coronary heart disease is disclosed.

Abstract: A milk which is free of &bgr;-casein A1 protein in the prevention or treatment of coronary heart disease is disclosed. In addition, a process for the testing of DNA from cells obtained from lactating bovines for the presence of DNA encoding certain &bgr;-casein proteins, selecting the bovines on the basis of the testing, and then milking those bovines to produce milk free of &bgr;-casein A1 for use in the prevention or treatment of coronary heart disease is disclosed.

Abstract: A milk or other dairy product, capable of minimising the onset of disease such as coronary heart disease or enhancing the immune response is derived from animals which are substantially free of the &bgr;-casein A1 allele. Bulk milk can be produced by testing for and culling cows who test positive for the &bgr;-casein A1 allele, or by producing immunoglobulins and other immune response proteins, in cow's milk from animals not possessing the &bgr;-casein A1 allele, or other commercial milk producing animals, to this allele, to counteract the immunosuppressant substances present that are produced from it, in commercial milking cows such as Holsteins, together with its blending with non-treated milk or the recovery of such immunoproteins.

Abstract: An article includes a ceramic member (5) and a composite member (9) bonded together. The composite member is formed of a substrate member and a deformable metal layer which is mechanically fixed to the substrate member. The substrate member is formed of a material which is harder than the deformable metal. The ceramic member and the deformable metal layer of the composite member are hermetically sealed together by a solid phase bond formed by ultrasonic welding.

Abstract: The cathode region of a sodium sulphur cell has hitherto sometimes been sealed by a thin metal member welded at its outer periphery to the metal casing and at its inner periphery to the alpha alumina lid of the electrolyte. The welding operation damages the essential protective coating of the thin metal member. This invention discloses sealing the cathode region with a thin metal member (5) secured to a concentric outer thicker metal member (4), the thin member being sealed to the lid (15) and the thicker member being sealed to the casing (1). The thickness of the outer member eliminates the need for a protective coating so that the combined seal has greater integrity than previous seals.

Abstract: Apparatus for constructing an alkali metal energy conversion device, for example a sodium sulphur cell. Such cells typically employ a solid electrolyte element separating cathodic and anodic reactants which are liquid at the cell operating temperature.

Abstract: A welding electrode arrangement comprising an inner electrode and a plurality of electrically interconnected outer electrodes defining a closed figure about the inner electrode, the outer electrodes being resilient in a direction substantially parallel to the axis of the closed figure, the outer electrodes further being in the form of a plurality of inwardly directed fingers extending from and integral with an outer connecting rim.

Abstract: Method of treating wool scouring liquor effluent to render it suitable for recycling or discharge and to concurrently recover wool grease as a by-product. The method comprises mixing scouring liquor effluent with sufficient alcohol to produce a concentration in excess of saturation to leave a discrete alcohol phase, adding a selected flocculant to effect a liquid/liquid separation of grease from the liquor and stripping the separated grease from the alcohol phase.